Gillian Tan, Columnist

Greenhill's Lifeline Still Leaves a Sick Patient

Without a meaningful rebound in advisory fees, it's no better than a Band-Aid.

September 25, 2017 at 11:14 PM UTC

Gillian Tan is a senior reporter covering finance and alternative asset classes including real estate, infrastructure, private equity, private credit, venture capital and sports business. She previously wrote an opinion column for Bloomberg and was a reporter at the Wall Street Journal. She is a qualified chartered accountant.

1506382810_pic — Photographer: Photographer: Victor J. Blue/Bloomberg

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

Has Greenhill & Co. Inc.'s Scott Bok been reading Gadfly?

Some six weeks after I wrote that the flailing boutique advisory firm should consider some self-help, it has bitten the bullet. Late on Monday, the New York-based investment bank revealed a dramatic plan to resuscitate its stock, which has slumped along with its fee pool as is struggled to win new business. Call it a last stand.